M&A / Deals Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant Pharmaceutical TechnologyVivani's NanoPortal technology delivers medication steadily over long periods of time.Metabolic & GLP-1Read full story pharminent July 8, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology Vivani’s NanoPortal technology delivers medication steadily over long periods of time. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novartis Pays $1.1B Upfront for Myricx Bio ADC PlatformNext: AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical Related Stories M&A / Deals Spero snaps up Innovent immunology drug in strategic pivot pharminent July 14, 2026 M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026 M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
